
| ASSET | DATE | % RETURN |
|---|---|---|
GreenPro Capital (GRNQ) | 7/5/2015 - 8/1/2015 | 414.29% |
Rocket Pharmaceuticals (RCKT) | 7/5/2015 - 8/1/2015 | 170.06% |
ABVC BioPharma (ABVC) | 7/5/2015 - 8/1/2015 | 150% |
Anavex Life Sciences (AVXL) | 7/5/2015 - 8/1/2015 | 101.35% |
Xenetic Biosciences (XBIO) | 7/5/2015 - 8/1/2015 | 100% |
ProMIS Neurosciences (PMN) | 7/5/2015 - 8/1/2015 | 100% |
Beam Global (BEEM) | 7/5/2015 - 8/1/2015 | 83.49% |
CEA Industries (BNC) | 7/5/2015 - 8/1/2015 | 82% |
Synergy CHC Corp Common Stock (SNYR) | 7/5/2015 - 8/1/2015 | 75% |
Exelixis (EXEL) | 7/5/2015 - 8/1/2015 | 70.03% |
Tvardi Therapeutics (TVRD) | 7/5/2015 - 8/1/2015 | 68.59% |
Ambow Education (AMBO) | 7/5/2015 - 8/1/2015 | 60% |
Skeena Resources (SKE) | 7/5/2015 - 8/1/2015 | 58.18% |
Achieve Life Sciences (ACHV) | 7/5/2015 - 8/1/2015 | 55.41% |
TON Strategy (TONX) | 7/5/2015 - 8/1/2015 | 53.08% |
Assertio Therapeutics (ASRT) | 7/5/2015 - 8/1/2015 | 52.91% |
Kiora Pharmaceuticals (KPRX) | 7/5/2015 - 8/1/2015 | 52.13% |
VerifyMe (VRME) | 7/5/2015 - 8/1/2015 | 50.48% |
CleanSpark (CLSK) | 7/5/2015 - 8/1/2015 | 50% |
DBV Technologies (DBVT) | 7/5/2015 - 8/1/2015 | 46.47% |
Aethlon Medical (AEMD) | 7/5/2015 - 8/1/2015 | 45.84% |
LifeMD (LFMD) | 7/5/2015 - 8/1/2015 | 44.44% |
Precigen (PGEN) | 7/5/2015 - 8/1/2015 | 43.28% |
Lipocine (LPCN) | 7/5/2015 - 8/1/2015 | 40.77% |
Oragenics (OGEN) | 7/5/2015 - 8/1/2015 | 40.11% |